Relay Therapeutics News

Relay Therapeutics | 10-Q: Quarterly report

May 2 16:20 ET

Relay Therapeutics | 8-K: Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights

May 2 16:16 ET

Relay Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rahmer Peter

Apr 29 20:40 ET

Relay Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Adams Brian

Apr 29 20:35 ET

Relay Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Catinazzo Thomas

Apr 29 20:35 ET

Relay Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bergstrom Donald A

Apr 29 20:35 ET

Relay Therapeutics | ARS: Annual Report to Security Holders

Apr 23 16:20 ET

Relay Therapeutics | DEFA14A: Others

Apr 23 16:15 ET

Relay Therapeutics | DEF 14A: Definitive information statements

Apr 23 16:11 ET

Relay Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Adams Brian

Mar 29 16:20 ET

Relay Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rahmer Peter

Mar 29 16:20 ET

Relay Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bergstrom Donald A

Mar 29 16:20 ET

Relay Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Catinazzo Thomas

Mar 29 16:19 ET

Relay Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 22 16:39 ET

Relay Therapeutics | 10-K: Annual report

Feb 22 16:25 ET

Relay Therapeutics | 8-K: Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights

Feb 22 16:14 ET

Relay Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Casdin Capital, LLC(5.99%),Eli Casdin(5.99%), etc.

Feb 14 17:44 ET

Relay Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-T. ROWE PRICE ASSOCIATES, INC.(7.0%)

Feb 14 10:17 ET

Relay Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(8.64%)

Feb 13 22:37 ET

Relay Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rahmer Peter

Jan 31 16:19 ET